NASDAQ:NBIX Neurocrine Biosciences - NBIX Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $97.21 +2.96 (+3.14%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$93.55▼$97.4950-Day Range$94.11▼$111.3652-Week Range$75.25▼$129.29Volume678,259 shsAverage Volume860,981 shsMarket Capitalization$9.39 billionP/E Ratio63.54Dividend YieldN/APrice Target$125.65 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$39.03 MNumber OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$29.12 M NBIX Insider Buying and Selling by Quarter Get NBIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Neurocrine Biosciences Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.448,575,316 2/8/2023Eric BenevichInsiderSell980$104.12$102,037.6034,381 2/8/2023Kevin Charles GormanCEOSell2,274$104.30$237,178.20491,365 2/7/2023Matt AbernethyCFOSell26,328$102.40$2,695,987.2024,333 2/6/2023Eric BenevichInsiderSell1,280$105.63$135,206.4017,879 2/6/2023Kevin Charles GormanCEOSell3,040$105.68$321,267.20468,008 1/31/2023Eiry RobertsInsiderSell1,457$109.99$160,255.4326,171 1/31/2023Kevin Charles GormanCEOSell2,707$110.08$297,986.56465,278 1/31/2023Matt AbernethyCFOSell1,283$109.98$141,104.3421,357 1/6/2023Eric BenevichInsiderSell400$125.00$50,000.0015,643 1/3/2023Stephen A SherwinDirectorSell30,000$118.86$3,565,800.0025,055 11/30/2022Eric BenevichInsiderSell50,000$125.90$6,295,000.0015,643 11/10/2022Eric BenevichInsiderSell100$125.36$12,536.0015,643 11/8/2022Eric BenevichInsiderSell24,593$125.33$3,082,240.6915,643 11/3/2022Darin LippoldtInsiderSell4,518$125.02$564,840.3629,234 11/1/2022Darin LippoldtInsiderSell10,000$120.09$1,200,900.0029,234 10/31/2022Gary A LyonsDirectorSell15,000$114.76$1,721,400.00203,697 10/27/2022Darin LippoldtInsiderSell4,923$115.04$566,341.9229,234 10/17/2022Eric BenevichInsiderSell4,960$110.82$549,667.2015,643 10/4/2022Gary A LyonsDirectorSell5,000$110.54$552,700.00203,697 10/3/2022David W BoyerInsiderSell1,437$106.59$153,169.834,214 8/12/2022Malcolm Lloyd-SmithInsiderSell21,533$105.95$2,281,421.3518,888 6/27/2022Julie CookeInsiderSell754$100.00$75,400.0016,918 5/9/2022Richard F PopsDirectorSell15,000$76.30$1,144,500.0029,512 4/25/2022Gary A LyonsDirectorSell15,000$92.76$1,391,400.00208,697 4/1/2022William H RastetterDirectorSell10,728$94.93$1,018,409.0434,022 3/22/2022Darin LippoldtInsiderSell8,455$95.05$803,647.75 (Data available from 1/1/2013 forward) NBIX Insider Trading Activity - Frequently Asked Questions Who is on Neurocrine Biosciences's Insider Roster? The list of insiders at Neurocrine Biosciences includes Darin Lippoldt, David W Boyer, Dimitri E Grigoriadis, Eiry Roberts, Eric Benevich, Gary A Lyons, Haig P Bozigian, Julie Cooke, Kevin Charles Gorman, Kyle Gano, Malcolm Lloyd-Smith, Matt Abernethy, Neurocrine Biosciences Inc, Richard F Pops, Stephen A Sherwin, and William H Rastetter. Learn more on insiders at NBIX. What percentage of Neurocrine Biosciences stock is owned by insiders? 4.40% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings. Which Neurocrine Biosciences insiders have been buying company stock? The following insider purchased NBIX shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44). How much insider buying is happening at Neurocrine Biosciences? Insiders have purchased a total of 4,395,588 NBIX shares in the last 24 months for a total of $39,032,821.44 bought. Which Neurocrine Biosciences insiders have been selling company stock? The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($3,164,230.03), David W Boyer ($172,626.63), Dimitri E Grigoriadis ($838,480.00), Eiry Roberts ($356,339.43), Eric Benevich ($10,731,069.25), Gary A Lyons ($5,193,500.00), Julie Cooke ($175,807.51), Kevin Charles Gorman ($1,560,374.16), Kyle Gano ($2,416,743.00), Malcolm Lloyd-Smith ($3,848,725.55), Matt Abernethy ($3,240,366.99), Richard F Pops ($1,144,500.00), Stephen A Sherwin ($4,682,250.00), and William H Rastetter ($1,018,409.04). How much insider selling is happening at Neurocrine Biosciences? Insiders have sold a total of 368,177 Neurocrine Biosciences shares in the last 24 months for a total of $38,543,421.59 sold. This page (NASDAQ:NBIX) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.